Andrea Buxton
Family · Green Bay, WINPI 1275232142
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $25,096 of the $35,519 with a category attached, or 70.7%. 9 manufacturers reported payments, led by CSL Behring at 55.6% of the total. Among family clinicians in WI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 80 payments — averaging $443.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- CSL Behring$20K
- Biomarin Pharmaceutical Inc.$12K
- Sanofi$3K
- Pfizer$115
- Exact Sciences$111
- Novo Nordisk$67
- plus $102 from 3 others
What the payments were for
- Consulting fees$3,88811%
- Speaking & faculty fees$25,09671%
- Travel & lodging$4,84714%
- Food & beverage$1,6885%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| CSL Behring | 32 | $19,745 |
| Biomarin Pharmaceutical Inc. | 26 | $12,042 |
| Sanofi | 10 | $3,338 |
| Pfizer | 4 | $115 |
| Exact Sciences | 1 | $111 |
| Novo Nordisk | 3 | $67 |
| Bayer | 2 | $52 |
| Octapharma USA, Inc. | 1 | $29 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$35,519 in reported general payments places this provider in the 95th percentile of 1,273 family providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OdefseyEmtricitab/Rilpiviri/Tenof Ala | 16 | $56,023 |
| OxycontinOxycodone Hcl | 20 | $12,992 |
| Meloxicam | 25 | $59 |
Paid to pharmacies, not to this prescriber.
Other family in Green Bay
- Jani CookGreen Bay$31K
- Diane VanderlinGreen Bay$5K
- Michele KreftGreen Bay$4K
- Stephanie OffordMilwaukee$116K
- Laura SwobodaMenomonee Falls$111K
- Lonniel BainMadison$54K
- Linda WespGlendale$44K
- Tiffany HolleySheboygan$26K
- Kathryn SweetmanMenomonee Falls$26K
- Tracy NelsonMilwaukee$24K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.